David W. Oslin

Association between medical comorbidity and treatment outcomes in late-life depression.

Assessment of late life depression.

Pharmacologic treatment of depression in nursing home residents: a mental health services perspective.

Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment.

Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes.

Treatment-related decisional capacity.

The pilot study of a telephone disease management program for depression.

Effect of increasing the dose and duration of sertraline trial in the treatment of depressed nursing home residents.

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

Alcohol-related dementia: validation of diagnostic criteria.

Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life.

Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.

A genetic association study of the mu opioid receptor and severe opioid dependence.

Disease management for depression and at-risk drinking via telephone in an older population of veterans.

Managing suicide risk in late life: access to firearms as a public health risk.

Design and sample characteristics of the PRISM-E multisite randomized trial to improve behavioral health care for the elderly.

Treatment effects from UPBEAT: a randomized trial of care management for behavioral health problems in hospitalized elderly patients.

Association of functional opioid receptor genotypes with alcohol dependence in Koreans.

Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use.

Late-life alcoholism: issues relevant to the geriatric psychiatrist.

Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action.

Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence.

Gambling among older, primary-care patients: an important public health concern.

Treatment of late-life depression complicated by alcohol dependence.

Lack of association between single nucleotide polymorphisms in the corticotropin releasing hormone receptor 1 (CRHR1) gene and alcohol dependence.

Importance of subsyndromal symptoms of depression in elderly patients.

Treatment outcomes for alcohol dependence among middle-aged and older adults.

Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence.

Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American population.

A functional prodynorphin promoter polymorphism and opioid dependence.

Evidence-based treatment of geriatric substance abuse.

Older patients' aversion to antidepressants. A qualitative study.

Screening, assessment, and management of depression in VA primary care clinics. The Behavioral Health Laboratory.

Family involvement in the care of healthy medical outpatients.

Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence.

PRISM-E: comparison of integrated care and enhanced specialty referral models in depression outcomes.

PRISM-E: comparison of integrated care and enhanced specialty referral in managing at-risk alcohol use.

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.

No association between polymorphisms in the prostate apoptosis factor-4 gene and cocaine dependence.

Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Effect of depression treatment on depressive symptoms in older adulthood: the moderating role of pain.

Alcohol consumption among older adults in primary care.

Psychiatrists and primary caring: what are our boundaries of responsibility?

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.

Longitudinal course of substance treatment benefits in older male veteran at-risk drinkers.

A randomized controlled trial of a close monitoring program for minor depression and distress.

A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.

Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.

Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients.

Family problems among recently returned military veterans referred for a mental health evaluation.

Psychological well-being among individuals aging with HIV: the value of social relationships.

Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.

The association between chronic pain and prescription drug abuse in Veterans.

Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.

Daily ratings measures of alcohol craving during an inpatient stay define subtypes of alcohol addiction that predict subsequent risk for resumption of drinking.

Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence.

Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study.

Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.

Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.

Implementing standardized assessments in clinical care: now's the time.

Alcohol misuse among the elderly: an opportunity for prevention.

Rational protection of subjects in research and quality improvement activities.

Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence.

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.

When late-life depression improves: what do older patients say about their treatment?

The Behavioral Health Laboratory: building a stronger foundation for the patient-centered medical home.

Predictors of sleep disturbances in Operation Iraqi Freedom/Operation Enduring Freedom veterans reporting a trauma.

Age group differences among veterans enrolled in a clinical service for behavioral health issues in primary care.

A randomized trial of extended telephone-based continuing care for alcohol dependence: within-treatment substance use outcomes.

Functional quality of life in full versus partial posttraumatic stress disorder among veterans returning from Iraq and Afghanistan.

Pharmacotherapy for alcohol dependence.

Psychiatric status and work performance of veterans of Operations Enduring Freedom and Iraqi Freedom.

Missed opportunities: fewer service referrals after positive alcohol misuse screens in VA primary care.

The psychiatric note in the era of electronic communication.

Differences in treatment attitudes between depressed African-American and Caucasian veterans in primary care.

Extended telephone-based continuing care for alcohol dependence: 24-month outcomes and subgroup analyses.

The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.

Identifying risk factors for marijuana use among veterans affairs patients.

Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study.

Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids.

Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.

Telephone-based behavioral health assessment for older adults starting a new psychiatric medication.

Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review.

The association between mental health and cognitive screening scores in older veterans.

Our job and their jobs: mental health clinicians and patients' work functioning.

Telephone-based care management for older adults initiated on psychotropic medication.

Suicidal ideation and social exchanges among at-risk veterans referred for a behavioral health assessment.

Recruiting older men for geriatric suicide research.

Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans.

Going Beyond Antidepressant Monotherapy for Incomplete Response in Nonpsychotic Late-Life Depression: A Critical Review.

PTSD Is a Chronic, Fluctuating Disorder Affecting the Mental Quality of Life in Older Adults.

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Case-control association study of WLS variants in opioid and cocaine addicted populations.

Going Beyond Antidepressant Monotherapy for Incomplete Response in Nonpsychotic Late-Life Depression: A Critical Review.

Substance abuse in older adults: review and recommendations for education and practice in medical settings.

Insomnia in alcohol dependence: predictors of symptoms in a sample of veterans referred from primary care.